BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Address
40 MARCUS DRIVE
MELVILLE, NY 11747
Founded
1997
Number of Employees
11
Website
http://www.biorestorative.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | $131 | $17 | - | - | $74 |
| Average Price | - | - | - | - | - | - | - | $6.56 | $3.06 | - | - | $5.79 |
| # Shares Purchased | - | - | - | - | - | - | - | 20,021 | 5,574 | - | - | 12,798 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | -84.7% | -67.3% | - | - | -82.7% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | - | - | 34.5% |
| Excess Total Return | - | - | - | - | - | - | - | -116.4% | -104.6% | - | - | -117.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | 3% | 6% | - | - | 4% |
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at BRTX make a trade.
Creating a free account takes less than one minute